Papers matching “T cell receptor engineering” 75
Not finding it? Sign in to also search OpenAlex live.
-
T-cell receptor engineering of primary NK-cells to therapeutically target tumours and tumour immune evasion2021 Research Square preprint Immunology and Microbiology Immune Cell Function and Interaction Open access
Laura T. Morton, Tassilo L A Wachsmann, Anne K. Wouters, Miranda H. Meeuwsen, Dennis F.G. Remst, Marleen van Loenen, +2 more
0citations -
T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion2022 Journal for ImmunoTherapy of Cancer article Immunology and Microbiology Immune Cell Function and Interaction Open access cited by 6 patents
Laura T. Morton, Tassilo L A Wachsmann, Miranda H. Meeuwsen, Anne K. Wouters, Dennis F.G. Remst, Marleen M. van Loenen, +2 more
34citations -
370 Identification and validation of a T cell receptor recognizing shared HLA-A02:01 presented epitope from TP53 frameshift2024 Regular and Young Investigator Award Abstracts conference-abstract Immunology and Microbiology Immunotherapy and Immune Responses Open access
Michael V. Martin, Saskia J A M Santegoets, Jamie van Langelaar, Wim van Esch, Hugo Olsman, Finn Edwards, +4 more
0citations -
A library of cancer testis specific T cell receptors for T cell receptor gene therapy2022 Molecular Therapy — Oncolytics article Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 2 patents
Marije A. J. de Rooij, Dennis F.G. Remst, Dirk M. van der Steen, Anne K. Wouters, Renate S. Hagedoorn, Michel G.D. Kester, +7 more
19citations -
HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study
Peter van Balen, Inge Jedema, Marleen M. van Loenen, Renate de Boer, H.M. van Egmond, Renate S. Hagedoorn, +9 more
42citations -
Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance2021 Frontiers in Immunology article Medicine CAR-T cell therapy research Open access cited by 6 patents
Yannick D. Müller, Leonardo M. R. Ferreira, Émilie Ronin, Patrick Ho, Vinh Q. Nguyen, Gaetano Faleo, +10 more
109citations -
Precision engineering of an anti-HLA-A2 chimeric antigen receptor in regulatory T cells for transplant immune tolerance2021 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine CAR-T cell therapy research Open access cited by 6 patents
Yannick D. Müller, Leonardo M. R. Ferreira, Émilie Ronin, Patrick Ho, Vinh Q. Nguyen, Gaetano Faleo, +10 more
11citations -
Chimeric HLA antibody receptor T cell therapy for humoral transplant rejection2024 Nephrology Dialysis Transplantation article Medicine Renal Transplantation Outcomes and Treatments Open access
Carolt Arana, Ainhoa García‐Busquets, M Nicoli, Sergi Betriu, Ilse Gille, Mirjam H.M. Heemskerk, +4 more
10citations -
Phase 1 clinical trial of CRISPR-engineered CAR19 universal T cells for treatment of children with refractory B cell leukemia2022 Science Translational Medicine article Medicine CAR-T cell therapy research Open access cited by 2 patents
Giorgio Ottaviano, Christos Georgiadis, Soragia Athina Gkazi, Farhatullah Syed, Hong Zhan, Annie Etuk, +52 more
204citations -
T-cell receptors targeting distinct FLT3-D835Y neoantigens display differential reactivity toward acute myeloid leukemia2026 Blood Immunology & Cellular Therapy article Medicine Acute Myeloid Leukemia Research Open access
Nadine Struckman, M. Willy Honders, Georgia Koutsoumpli, Rob C. M. de Jong, Dyantha I. van der Lee, Michel G.D. Kester, +11 more
0citations -
The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer2022 Cancer Immunology Immunotherapy article Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 1 patent
Saskia J A M Santegoets, Marij J.P. Welters, Deborah S. Schrikkema, Manon R. Freriks, Hanna Kok, Bianca Weißbrich, +6 more
13citations -
148 Primary or iPSC-derived cell-based cytotoxicity assays to assess potential safety risks of engineered T cell therapies in vitro2021 Regular and Young Investigator Award Abstracts conference-abstract Medicine CAR-T cell therapy research Open access
Sophie Vermond, Monique Hazenoot, Rene J. McLaughlin, Sabrina de Munnik, Marco Guadagnoli, Gemma Moiset, +2 more
0citations -
CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden2023 Journal for ImmunoTherapy of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access
Jitske van den Bulk, Manon van der Ploeg, Marieke E. Ijsselsteijn, Dina Ruano, Ruud van der Breggen, Rebekka Duhen, +6 more
29citations -
Automated manufacture of ΔNPM1 TCR-engineered T cells for AML therapy2024 Molecular Therapy — Methods & Clinical Development article Medicine CAR-T cell therapy research Open access
Isabella Elias Yonezawa Ogusuku, Vera Herbel, Simon Lennartz, Caroline Brandes, Eva M. Argiro, C. Fabian, +12 more
8citations -
T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes2021 Nature Biotechnology article Medicine CAR-T cell therapy research Open access cited by 7 patents
Muhammad Ali, Eirini Giannakopoulou, Yingqian Li, Madeleine Lehander, Stina Virding Culleton, Weiwen Yang, +27 more
36citations -
TCR-engineered T-cells directed against Ropporin-1 constitute a safe and effective treatment for triple-negative breast cancer in near-clinical models2024 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine CAR-T cell therapy research Open access
Dian Kortleve, Dora Hammerl, Mandy van Brakel, Rebecca Wijers, Daphne Roelofs, Kim Kroese, +14 more
1citations